POSB125 The Impact of Discounting on the Cost Effectiveness of Tisagenlecleucel for Relapsed/Refractory Acute Lymphoblastic Leukaemia

Autor:	N Carey, L Mccullagh, M Barry
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S85-S86
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3f6c831021bec9195246cdf76441a1ab https://doi.org/10.1016/j.jval.2021.11.398 Zobrazit plný text záznamu Full Text from ScienceDirect